A 2120New Jersey
Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
In committee
Jan 13, 2026: Introduced, Referred to Assembly Aging and Human Services Committee